samedan logo

 
 
spacer
home > white papers > Clinical Trials in Russia Orange Paper: Summary of Year 2013 - Synergy Research Group
WHITE PAPERS
logo_Synergy_Re.JPG

Synergy Research Group

phone +7 495 600 4445
email request@synrg-pharm.com
web http://www.synrg-pharm.com
email 11, 4-Magistralnaya Ul., 123007 Moscow, Russia

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials.
Sponsors mention the following reasons for conducting studies in Russia:
1. Fast patient enrollment due to the centralized medical infrastructure.
2. Nearly 100% patient retention
3. GCP trained and certified Investigative Sites generating high quality data
4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
Clinical Trials in Russia Orange Paper: Summary of Year 2013
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Saudia Cargo kicks off twice a week Passenger as freighter flight to Copenhagen

May 2021 JEDDAH, KSA – Saudia Cargo kicked off, on Saturday 22 May 2021, its twice a week Passenger as freighter flights to Denmark’s capital Copenhagen, widening its route network in Scandinavia for pharmaceuticals and perishables. Saudia Airlines B777-300 passenger planes with 140-ton payload capacity per flight are being utilized as “preighters” on the route scheduled for Wednesday and Saturday.
More info >>


White Papers

Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement